Increased Local Failure for Patients with Intermediate-Risk Rhabdomyosarcoma on ARST0531: A Report from the Children’s Oncology Group

BACKGROUND: To evaluate local control for patients with intermediate-risk rhabdomyosarcoma (RMS) treated on Children’s Oncology Group (COG) protocol ARST0531. METHODS: We analyzed 424 patients with intermediate-risk RMS. Patients were randomized to chemotherapy with either vincristine, dactinomycin,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Casey, Dana L., Chi, Yueh-Yun, Donaldson, Sarah S., Hawkins, Douglas S., Tian, Jing, Arndt, Carola A., Rodeberg, David A., Routh, Jonathan C., Lautz, Timothy B., Gupta, Abha A., Yock, Torunn I., Wolden, Suzanne L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6717036/
https://ncbi.nlm.nih.gov/pubmed/31174239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32204
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados